- Home
- ESP vs SLS Comparison
ESP vs SLS Comparison
Compare ESP & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- SLS
- Stock Information
- Founded
- ESP 1928
- SLS 2012
- Country
- ESP United States
- SLS United States
- Employees
- ESP N/A
- SLS N/A
- Industry
- ESP Industrial Machinery/Components
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- SLS Health Care
- Exchange
- ESP Nasdaq
- SLS Nasdaq
- Market Cap
- ESP 84.1M
- SLS 89.6M
- IPO Year
- ESP N/A
- SLS N/A
- Fundamental
- Price
- ESP $27.60
- SLS $1.09
- Analyst Decision
- ESP
- SLS
- Analyst Count
- ESP 0
- SLS 0
- Target Price
- ESP N/A
- SLS N/A
- AVG Volume (30 Days)
- ESP 13.3K
- SLS 815.8K
- Earning Date
- ESP 05-12-2025
- SLS 03-20-2025
- Dividend Yield
- ESP 3.61%
- SLS N/A
- EPS Growth
- ESP 31.14
- SLS N/A
- EPS
- ESP 2.45
- SLS N/A
- Revenue
- ESP $43,917,522.00
- SLS N/A
- Revenue This Year
- ESP N/A
- SLS N/A
- Revenue Next Year
- ESP N/A
- SLS N/A
- P/E Ratio
- ESP $11.06
- SLS N/A
- Revenue Growth
- ESP 18.62
- SLS N/A
- 52 Week Low
- ESP $20.20
- SLS $0.77
- 52 Week High
- ESP $33.00
- SLS $1.84
- Technical
- Relative Strength Index (RSI)
- ESP 56.92
- SLS 40.56
- Support Level
- ESP $26.50
- SLS $1.13
- Resistance Level
- ESP $27.75
- SLS $1.25
- Average True Range (ATR)
- ESP 0.60
- SLS 0.07
- MACD
- ESP 0.17
- SLS -0.01
- Stochastic Oscillator
- ESP 92.15
- SLS 17.39
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.